Proton NMR analysis of plasma is a weak predictor of coronary artery disease. - Wikidata - wikimedia - TriplyDB

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

http://www.wikidata.org/entity/Q48547379

about

Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury Metabolomics and cardiovascular biomarker discovery Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data.Metabolomic analysis of human disease and its application to the eye.Interrogating causal pathways linking genetic variants, small molecule metabolites, and circulating lipids Biomarkers and cardiovascular risk assessment for primary prevention: an update.Metabolomic analyses for atherosclerosis, diabetes, and obesity.Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases.The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective Metabolic fingerprinting as a diagnostic tool.Current challenges in metabolomics for diabetes research: a vital functional genomic tool or just a ploy for gaining funding?The emerging role of metabolomics in the development of biomarkers for pulmonary hypertension and other cardiovascular diseases (2013 Grover Conference series)Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.Circulating, imaging, and genetic biomarkers in cardiovascular risk prediction Modeling hormonal and inflammatory contributions to preterm and term labor using uterine temporal transcriptomics.NMR-based prediction of cardiovascular risk in diabetes.Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials?Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders.Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool.Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.High heritability of metabolomic profiles in families burdened with premature cardiovascular disease.Application of metabolomics to cardiovascular biomarker and pathway discovery.Metabolomics-based methods for early disease diagnostics Postgenomics diagnostics: metabolomics approaches to human blood profiling.The impact of inflammation on metabolomic profiles in patients with arthritis.Metabolomics applied to diabetes research: moving from information to knowledge 1H NMR-based metabolite profiling of plasma in a rat model of chronic kidney disease.Metabolomics and atherosclerosis.Using metabolomic analysis to understand inflammatory bowel diseases.The role of metabolites and metabolomics in clinically applicable biomarkers of disease.An introduction to biological nuclear magnetic resonance spectroscopy.Metabolomics as a tool for cardiac research.Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook.

P2860

Q24657261-2625649C-4215-48A6-BBDC-AA14DE2FA4D7 Q26991473-96D2E0BA-CDF8-4DA9-BFE0-5F48EE04BE64 Q28469239-2247C9E2-55D0-4215-946D-1EFEAEA561D6 Q31112222-ECFB2423-8FAF-466E-9062-997B38BABBF5 Q33631499-1256BFEE-DDC5-4F74-AC26-E06E366E689D Q33772596-5A68416A-07A4-472A-8F67-0624373BAE3B Q33927398-5F4ADB8E-E67F-4B76-A63B-E4FB3190B666 Q34256164-ED784033-79AA-4254-9254-A7A182D85954 Q34497155-A1F4015F-BA72-43C5-9DBA-9B2BF0762AED Q34513438-CFAFE409-1044-4F5B-967E-0BE0643039A3 Q34699756-EB53B746-9F90-400B-9913-F4C1D05E975B Q34770015-0A84F28A-2802-4605-807D-863532471AEB Q34782469-514E3C8B-7A77-4DF5-BF8E-30C48F110BBA Q35219088-020FB4A9-648A-4228-8097-60CA8B9CAD33 Q35534297-0FF96C55-F784-4960-ADD0-16058ADFEF1B Q36037541-53D8D86C-B406-4735-8851-AD534D093B5A Q36049696-B9D0A46B-262E-4F6D-9198-28A745007F04 Q36145624-90E5097F-DDE5-4113-8492-721EF078CC70 Q36245143-5DF1A747-5BDB-47CA-8413-2297A63778C6 Q36328994-F4D6FDC7-E05D-4E59-A34F-B07C02807683 Q36496258-0B69F365-B29A-4412-8040-DC8C3B29F39B Q36630007-677C7CDC-D1BF-4490-A73F-8E684A05D7C8 Q36630012-4D85CAE0-8983-4297-A57F-ED1F62DAE8FA Q36779120-4DEA2AA1-7BEA-425B-A976-3B3A70F74B47 Q36808058-C4A1F41B-35D4-439F-94EA-8654CA23312A Q37004622-C364AF22-6A84-47C0-9C80-F6BFAC9AF88A Q37004712-56223A1F-E680-447A-BD57-762286095D4A Q37196164-D3FCC54E-8C99-445B-A8B2-8390025869F5 Q37206431-D2760DC7-761C-4729-9000-D04E34F19082 Q37266489-50D84AB5-4976-41F1-B91F-5C7768FB13C2 Q37272725-852A0E2C-542E-455D-B394-08210010827F Q37343272-9703BEC8-FA30-48B9-A7CA-92ED949159DA Q37400761-08669EB8-9BC1-4EAA-BB75-CEADB7C21582 Q37495723-0B37A7E4-F76D-416A-95E9-7AA1FEDA2B14 Q37750547-1E6280F8-1E73-4234-B824-58206BF94FDF Q37772447-B593DC78-1F33-404A-9AE5-53DFAA9F89EE Q37800811-81EF7299-FCD9-429F-BCF9-1B7113E1D6B6 Q37802449-821D9D7A-4F62-4192-8298-3333A97102E5 Q37935537-AA3C0594-C6DA-415C-9EA6-88E44541ABC3 Q37943853-7C4E898F-26D6-4012-86EF-99169A7E9340

P2860

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

http://www.wikidata.org/entity/Q48547379

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@en

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@nl

type

label

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@en

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@nl

prefLabel

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@en

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@nl

P1433

Q48547379-B745B331-F893-49FC-99B7-037EB9628F09

P1476

Q48547379-64C333B2-E0FB-4D92-9A8D-28549D10BD73

P2093

Q48547379-2D6DE611-1890-4251-8C8A-D9B223D96CB4

Q48547379-5DB5ED39-E77E-4D16-893F-4FBAA1E618C9

Q48547379-6DC7725F-176F-44F1-8AFD-3F27E7CA9C01

Q48547379-A6071029-2950-48F7-86F1-0279841CA84D

Q48547379-C879D49E-E0A8-4747-B3E7-7D34D02751E5

Q48547379-D1BC5DF7-B60A-4D4C-B222-0DEBFD74C326

Q48547379-DA1B5D0C-80A0-441D-81EF-0D043E389474

Q48547379-DB25E8BF-8D7D-45F8-A84A-0CCF49340A79

P2860

Q48547379-0B61EFD3-FD15-4B05-BC62-8F10EB572BFB

Q48547379-0F21C4B0-04F2-438C-8B6F-A4E6DC16679C

Q48547379-14AA7834-C75C-4B68-8758-9BF1DC5879B5

Q48547379-213A7A52-31B7-47CE-9C9A-BFDD1D8FD266

Q48547379-3C05FA98-B832-4CBC-BFAD-66F78FC99808

Q48547379-4000063D-216D-4CDA-9FDD-306FE4A20D60

Q48547379-443B80CC-CFC4-45DD-AF3D-B644A3F7D22E

Q48547379-44BBC2CB-CC12-420E-846F-C0D32C129228

Q48547379-460EAF18-2645-41C8-83FE-07822C7211D9

Q48547379-8A34EF67-8332-48B9-A135-51C0B2F7FA30

P2888

Q48547379-B8098D38-29F2-441C-8DE5-F32F5DCB0668

P304

Q48547379-78A682B2-3BE3-4EC8-A7A2-580DF21918DE

P31

Q48547379-989DDD12-9C5D-46A6-9910-71265D44CEAD

P356

Q48547379-C24FFB6C-D021-448D-9704-947EF6244147

P407

Q48547379-06C4184B-7D02-4DF0-A12B-BF8BD04A181F

P433

Q48547379-53BDB2FD-EF24-4A6A-8936-E241D32FBABD

P478

Q48547379-857890F4-0E6D-4BDE-850D-D32D3B5AF8EA

P577

Q48547379-A09F01B0-8967-43D6-B3D7-C1B4FA259C28

P698

Q48547379-4AE2A056-B053-4FEF-82C5-54F7DA965DED

P356

P1433

Nature Medicine

P1476

Proton NMR analysis of plasma is a weak predictor of coronary artery disease.

@en

P2093

Andrew A Grace

http://www.w3.org/2001/XMLSchema#string

Heide L Kirschenlohr

http://www.w3.org/2001/XMLSchema#string

James C Metcalfe

http://www.w3.org/2001/XMLSchema#string

Julian L Griffin

http://www.w3.org/2001/XMLSchema#string

Kevin M Brindle

http://www.w3.org/2001/XMLSchema#string

Peter M Schofield

http://www.w3.org/2001/XMLSchema#string

Ranyl Rhydwen

http://www.w3.org/2001/XMLSchema#string

Sarah C Clarke

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis

MR spectroscopy quantitation: a review of frequency domain methods.

Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension.

Improved method for accurate and efficient quantification of MRS data with use of prior knowledge

Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy.

Lipoprotein abnormalities related to women's health.

Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.

Bias as a threat to the validity of cancer molecular-marker research.

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.

P2888

P304

705-710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1432

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16732278

http://www.w3.org/2001/XMLSchema#string